Furthermore, apart from some well-known favorable prognosticators including high preoperative KPS (Karnofsky Performance Status, hazard ratio, 0.498; 95% CI, 0.282–0.878; p = 0.016) and receiving chemoradiotherapy (hazard ratio, 0.434; 95% CI, 0.257–0.732; p = 0.002), SCG3 positivity was also shown by a multivariate Cox regression model as another independent predictor for better outcomes in this cohort of GBM patients (Table 1). Here, SCG3 is linked to glioblastoma.